Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT01556451
Eligibility Criteria:
Inclusion Criteria:
* No fever on day of vaccination
* Females have a negative pregnancy test and use an acceptable method of birth control, or are postmenopausal
* Underlying chronic illness must be stable
Exclusion Criteria:
* History of hypersensitivity reaction to any vaccine component
* Prior history of herpes zoster
* Prior receipt of varicella or zoster vaccine
* Pregnant or breastfeeding
* Have recently received immunoglobulins or blood products other than autologous blood transfusion
* Received any inactivated other live virus vaccine within 4 weeks prior to vaccination, or is expected to received any other live virus vaccine during the duration of the study
* Received any inactivated vaccine within 7 days prior to vaccination, or is expected to receive any inactivated vaccine during the duration of the study
* Use of immunosuppressive therapy
* Known or suspected immune dysfunction
* Use of nontopical antiviral therapy with activity against herpes virus
* Known or suspected active untreated tuberculosis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT01556451
Study Brief:
Protocol Section:
NCT01556451